KURA vs. NVDA
KURA (Kura Oncology, Inc.) and NVDA (NVIDIA Corporation) are both stocks. KURA operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 10 years, KURA returned 8.46%/yr vs 64.62%/yr for NVDA. Their 0.22 correlation means their historical movements had little consistent relationship.
Performance
KURA vs. NVDA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KURA achieves a -13.28% return, which is significantly lower than NVDA's 7.77% return. Over the past 10 years, KURA has underperformed NVDA with an annualized return of 8.46%, while NVDA has yielded a comparatively higher 64.62% annualized return.
KURA
- 1D
- -3.22%
- 1M
- -18.83%
- 6M
- 10.96%
- YTD
- -13.28%
- 1Y
- 49.67%
- 3Y*
- -4.49%
- 5Y*
- -13.81%
- 10Y*
- 8.46%
- ALL TIME*
- 1.11%
NVDA
- 1D
- 2.93%
- 1M
- 3.04%
- 6M
- 5.16%
- YTD
- 7.77%
- 1Y
- 15.71%
- 3Y*
- 62.93%
- 5Y*
- 59.52%
- 10Y*
- 64.62%
- ALL TIME*
- 36.28%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $11.60M | $15.26M | $17.77M | |
| $25.46B | $26.13B | $31.85B |
KURA vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KURA Kura Oncology, Inc. | -13.28% | 19.29% | -39.43% | 15.87% | -11.36% | -57.13% | 137.53% | -2.07% | -8.24% | 159.32% |
NVDA NVIDIA Corporation | 7.77% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
Correlation
The correlation between KURA and NVDA is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.21 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Nov 5, 2015 | 0.22 |
Fundamentals
KURA:
$799.86M
NVDA:
$4.86T
KURA:
-$3.34
NVDA:
$6.53
KURA:
11.08
NVDA:
19.35
KURA:
7.40
NVDA:
25.05
KURA:
$71.64M
NVDA:
$253.49B
KURA:
$67.71M
NVDA:
$187.95B
KURA:
-$304.14M
NVDA:
$192.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KURA vs. NVDA — Risk / Return Rank
KURA
NVDA
KURA vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kura Oncology, Inc. (KURA) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KURA | NVDA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.44 | ||
| Sortino ratioReturn per unit of downside risk | +0.79 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.09 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 1.26 | 0.65 | +0.61 |
| Martin ratioReturn relative to average drawdown | 2.51 | 1.32 | +1.19 |
Loading charts...
Drawdowns
KURA vs. NVDA - Drawdown Comparison
The maximum KURA drawdown since its inception was -86.69%, roughly equal to the maximum NVDA drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for KURA and NVDA.
Loading charts...
Drawdown Indicators
| KURA | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.69% | -89.72% | +3.03% |
Max Drawdown (1Y)Largest decline over 1 year | -39.04% | -20.21% | -18.83% |
Max Drawdown (3Y)Largest decline over 3 years | -76.46% | -36.88% | -39.58% |
Max Drawdown (5Y)Largest decline over 5 years | -76.46% | -66.34% | -10.12% |
Max Drawdown (10Y)Largest decline over 10 years | -86.69% | -66.34% | -20.35% |
Current DrawdownCurrent decline from peak | -78.35% | -14.74% | -63.61% |
Average DrawdownAverage peak-to-trough decline | -47.60% | -36.07% | -11.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.53% | 9.90% | +9.63% |
Volatility
KURA vs. NVDA - Volatility Comparison
Kura Oncology, Inc. (KURA) has a higher volatility of 17.27% compared to NVIDIA Corporation (NVDA) at 12.04%. This indicates that KURA's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KURA | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.27% | 12.04% | +5.23% |
Volatility (6M)Calculated over the trailing 6-month period | 39.63% | 28.30% | +11.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.33% | 36.41% | +24.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.39% | 51.87% | +10.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.81% | 49.95% | +18.86% |
Dividends
KURA vs. NVDA - Dividend Comparison
KURA has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.14%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KURA Kura Oncology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.14% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Financials
KURA vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Kura Oncology, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KURA and NVDA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KURA has higher volatility (17.27%) compared to NVDA (12.04%). In terms of maximum drawdown, KURA dropped -86.69% vs NVDA's -89.72%.
KURA currently has the higher Sharpe Ratio (0.80 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KURA and NVDA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer